CytomX Therapeutics, Inc. - Common Stock (CTMX)
CUSIP: 23284F105
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 169,491,059
- Total 13F shares
- 53,661,262
- Share change
- +78,437
- Total reported value
- $143,355,949
- Put/Call ratio
- 68%
- Price per share
- $2.67
- Number of holders
- 112
- Value change
- -$1,754,233
- Number of buys
- 51
- Number of sells
- 52
Quarterly Holders Quick Answers
What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23284F105:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. |
13F
|
Company |
3.7%
|
6,303,025
|
$27,292,000 | — | 31 Dec 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.6%
|
6,029,700
|
$26,109,000 | — | 31 Dec 2021 | |
| BVF INC/IL |
13F
|
Company |
3.4%
|
5,803,700
|
$25,130,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
5,107,991
|
$22,118,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
4,962,362
|
$21,488,000 | — | 31 Dec 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.9%
|
3,214,509
|
$13,919,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
2,739,544
|
$11,862,000 | — | 31 Dec 2021 | |
| Rubric Capital Management LP |
13F
|
Company |
1.4%
|
2,406,449
|
$10,420,000 | — | 31 Dec 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
1%
|
1,760,812
|
$7,624,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.75%
|
1,266,922
|
$5,486,000 | — | 31 Dec 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.73%
|
1,238,911
|
$5,364,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
1,173,847
|
$5,082,000 | — | 31 Dec 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.58%
|
980,085
|
$4,244,000 | — | 31 Dec 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.57%
|
961,474
|
$4,163,000 | — | 31 Dec 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.39%
|
663,800
|
$2,874,000 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.39%
|
659,863
|
$2,857,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
636,946
|
$2,758,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
615,321
|
$2,664,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
0.32%
|
536,422
|
$2,322,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.31%
|
522,027
|
$2,260,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.3%
|
505,500
|
$2,189,000 | — | 31 Dec 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.24%
|
411,222
|
$1,779,000 | — | 31 Dec 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.21%
|
357,134
|
$1,546,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.18%
|
307,229
|
$1,330,000 | — | 31 Dec 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.17%
|
288,326
|
$1,248,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
199,530
|
$1,229,000 | — | 31 Dec 2021 | |
| AXA S.A. |
13F
|
Company |
0.15%
|
250,900
|
$1,086,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
213,085
|
$923,000 | — | 31 Dec 2021 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.12%
|
201,758
|
$874,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
201,600
|
$873,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
184,965
|
$801,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
164,014
|
$711,000 | — | 31 Dec 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.09%
|
152,369
|
$660,000 | — | 31 Dec 2021 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
152,345
|
$660,000 | — | 31 Dec 2021 | |
| Clearline Capital LP |
13F
|
Company |
0.09%
|
145,000
|
$628,000 | — | 31 Dec 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.09%
|
144,160
|
$624,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
140,481
|
$608,000 | — | 31 Dec 2021 | |
| PDT Partners, LLC |
13F
|
Company |
0.08%
|
135,123
|
$585,000 | — | 31 Dec 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.08%
|
131,051
|
$567,000 | — | 31 Dec 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.08%
|
130,769
|
$566,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
126,703
|
$549,000 | — | 31 Dec 2021 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.07%
|
120,000
|
$520,000 | — | 31 Dec 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
112,933
|
$489,000 | — | 31 Dec 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.06%
|
107,365
|
$465,000 | — | 31 Dec 2021 | |
| STRS OHIO |
13F
|
Company |
0.06%
|
106,900
|
$462,000 | — | 31 Dec 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
104,560
|
$452,000 | — | 31 Dec 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.06%
|
96,905
|
$420,000 | — | 31 Dec 2021 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.05%
|
90,846
|
$393,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
87,143
|
$376,000 | — | 31 Dec 2021 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.05%
|
84,179
|
$365,000 | — | 31 Dec 2021 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock (CTMX) as of Q1 2022
As of 31 Mar 2022,
CytomX Therapeutics, Inc. - Common Stock (CTMX) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,661,262 shares.
The largest 10 holders included
BVF INC/IL, RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., Point72 Asset Management, L.P., Rubric Capital Management LP, MILLENNIUM MANAGEMENT LLC, ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and Candriam Luxembourg S.C.A..
This page lists
112
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
106
Q1 2022 holders
112
Holder diff
6
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.